Adenosine A2A and A2B receptor expression in neuroendocrine tumours: potential targets for therapy. (Record no. 21346149)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01516 a2200421 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250516065159.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201307s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1573-9546 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1007/s11302-011-9280-5 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Kalhan, A |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20130710 |
245 00 - TITLE STATEMENT | |
Title | Adenosine A2A and A2B receptor expression in neuroendocrine tumours: potential targets for therapy. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Purinergic signalling |
Date of publication, distribution, etc. | Jun 2012 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 265-74 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Journal Article; Research Support, Non-U.S. Gov't |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antineoplastic Agents |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cell Line, Tumor |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Drug Delivery Systems |
General subdivision | methods |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Gene Expression Regulation, Neoplastic |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Neuroendocrine Tumors |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Purinergic P1 Receptor Agonists |
General subdivision | pharmacology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Purinergic P1 Receptor Antagonists |
General subdivision | pharmacology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Receptor, Adenosine A2A |
General subdivision | biosynthesis |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Receptor, Adenosine A2B |
General subdivision | biosynthesis |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Gharibi, B |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Vazquez, M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Jasani, B |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Neal, J |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Kidd, M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Modlin, I M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Pfragner, R |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Rees, D A |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Ham, J |
773 0# - HOST ITEM ENTRY | |
Title | Purinergic signalling |
Related parts | vol. 8 |
-- | no. 2 |
-- | p. 265-74 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1007/s11302-011-9280-5">https://doi.org/10.1007/s11302-011-9280-5</a> |
Public note | Available from publisher's website |
No items available.